Literature DB >> 24150468

Conjunctivitis: a systematic review of diagnosis and treatment.

Amir A Azari1, Neal P Barney.   

Abstract

IMPORTANCE: Conjunctivitis is a common problem.
OBJECTIVE: To examine the diagnosis, management, and treatment of conjunctivitis, including various antibiotics and alternatives to antibiotic use in infectious conjunctivitis and use of antihistamines and mast cell stabilizers in allergic conjunctivitis. EVIDENCE REVIEW: A search of the literature published through March 2013, using PubMed, the ISI Web of Knowledge database, and the Cochrane Library was performed. Eligible articles were selected after review of titles, abstracts, and references.
FINDINGS: Viral conjunctivitis is the most common overall cause of infectious conjunctivitis and usually does not require treatment; the signs and symptoms at presentation are variable. Bacterial conjunctivitis is the second most common cause of infectious conjunctivitis, with most uncomplicated cases resolving in 1 to 2 weeks. Mattering and adherence of the eyelids on waking, lack of itching, and absence of a history of conjunctivitis are the strongest factors associated with bacterial conjunctivitis. Topical antibiotics decrease the duration of bacterial conjunctivitis and allow earlier return to school or work. Conjunctivitis secondary to sexually transmitted diseases such as chlamydia and gonorrhea requires systemic treatment in addition to topical antibiotic therapy. Allergic conjunctivitis is encountered in up to 40% of the population, but only a small proportion of these individuals seek medical help; itching is the most consistent sign in allergic conjunctivitis, and treatment consists of topical antihistamines and mast cell inhibitors. CONCLUSIONS AND RELEVANCE: The majority of cases in bacterial conjunctivitis are self-limiting and no treatment is necessary in uncomplicated cases. However, conjunctivitis caused by gonorrhea or chlamydia and conjunctivitis in contact lens wearers should be treated with antibiotics. Treatment for viral conjunctivitis is supportive. Treatment with antihistamines and mast cell stabilizers alleviates the symptoms of allergic conjunctivitis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24150468      PMCID: PMC4049531          DOI: 10.1001/jama.2013.280318

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  78 in total

Review 1.  Adenovirus advances: new diagnostic and therapeutic options.

Authors:  Herbert E Kaufman
Journal:  Curr Opin Ophthalmol       Date:  2011-07       Impact factor: 3.761

2.  [Comparative research of the efficacy of the gatifloxacin and levofloxacin for bacterial conjunctivitis in human eyes].

Authors:  Lan Gong; Xing-huai Sun; Xiao-di Qiu; Yue-qin Zhang; Jia Qu; Zhi-lan Yuan; Quan-chen Xiong
Journal:  Zhonghua Yan Ke Za Zhi       Date:  2010-06

Review 3.  Bacterial conjunctivitis.

Authors:  John Epling
Journal:  BMJ Clin Evid       Date:  2010-03-15

Review 4.  Treatment of viral conjunctivitis with antiviral drugs.

Authors:  Chrysanthi L Skevaki; Ioanna E Galani; Michail V Pararas; Konstantina P Giannopoulou; Athanassios Tsakris
Journal:  Drugs       Date:  2011-02-12       Impact factor: 9.546

5.  Sexually transmitted diseases treatment guidelines, 2010.

Authors:  Kimberly A Workowski; Stuart Berman
Journal:  MMWR Recomm Rep       Date:  2010-12-17

6.  Ocular manifestations in herpes zoster ophthalmicus.

Authors:  L R Puri; G B Shrestha; D N Shah; M Chaudhary; A Thakur
Journal:  Nepal J Ophthalmol       Date:  2011 Jul-Dec

7.  Efficacy and tolerability of besifloxacin ophthalmic suspension 0.6% administered twice daily for 3 days in the treatment of bacterial conjunctivitis: a multicenter, randomized, double-masked, vehicle-controlled, parallel-group study in adults and children.

Authors:  Bruce E Silverstein; Catherine Allaire; Kirk M Bateman; Lynne S Gearinger; Timothy W Morris; Timothy L Comstock
Journal:  Clin Ther       Date:  2011-01       Impact factor: 3.393

Review 8.  Diagnosis and management of red eye in primary care.

Authors:  Holly Cronau; Ramana Reddy Kankanala; Thomas Mauger
Journal:  Am Fam Physician       Date:  2010-01-15       Impact factor: 3.292

9.  Efficacy and safety of azithromycin 1.5% eye drops for purulent bacterial conjunctivitis in pediatric patients.

Authors:  Dominique Bremond-Gignac; Patricia Mariani-Kurkdjian; Ariel Beresniak; Lamia El Fekih; Yasmin Bhagat; Pascale Pouliquen; Laurent Delval; Pablo Goldschmidt; Edouard Bingen; Isabelle Cochereau
Journal:  Pediatr Infect Dis J       Date:  2010-03       Impact factor: 2.129

Review 10.  Estimate of the direct and indirect annual cost of bacterial conjunctivitis in the United States.

Authors:  Andrew F Smith; Curtis Waycaster
Journal:  BMC Ophthalmol       Date:  2009-11-25       Impact factor: 2.209

View more
  96 in total

1.  Comment on 'The accuracy of the Edinburgh Red Eye Diagnostic Algorithm'.

Authors:  T N Soomro; J Buchan
Journal:  Eye (Lond)       Date:  2015-10-16       Impact factor: 3.775

2.  Eye Symptom Questionnaire to Evaluate Anterior Eye Health.

Authors:  Maria A Woodward; Nita G Valikodath; Paula Anne Newman-Casey; Leslie M Niziol; David C Musch; Paul P Lee
Journal:  Eye Contact Lens       Date:  2018-11       Impact factor: 2.018

Review 3.  Management of Extraocular Infections.

Authors:  Srinivasan Muthiah; Naveen Radhakrishnan
Journal:  Indian J Pediatr       Date:  2017-07-14       Impact factor: 1.967

Review 4.  Common eye infections.

Authors:  Stephanie Watson; Maria Cabrera-Aguas; Pauline Khoo
Journal:  Aust Prescr       Date:  2018-06-01

5.  Surveillance Tools Emerging From Search Engines and Social Media Data for Determining Eye Disease Patterns.

Authors:  Michael S Deiner; Thomas M Lietman; Stephen D McLeod; James Chodosh; Travis C Porco
Journal:  JAMA Ophthalmol       Date:  2016-09-01       Impact factor: 7.389

6.  Red Eye: A Guide for Non-specialists.

Authors:  Andreas Frings; Gerd Geerling; Marc Schargus
Journal:  Dtsch Arztebl Int       Date:  2017-04-28       Impact factor: 5.594

7.  Discovery to Launch of Anti-allergy (Emadine; Patanol/Pataday/Pazeo) and Anti-glaucoma (Travatan; Simbrinza) Ocular Drugs, and Generation of Novel Pharmacological Tools Such as AL-8810.

Authors:  Najam A Sharif
Journal:  ACS Pharmacol Transl Sci       Date:  2020-11-05

8.  Formulation and comparative evaluation of HPMC and water soluble chitosan-based sparfloxacin nanosuspension for ophthalmic delivery.

Authors:  Nitin Prabhakar Ambhore; Panchaxari Mallapa Dandagi; Anand Panchakshari Gadad
Journal:  Drug Deliv Transl Res       Date:  2016-02       Impact factor: 4.617

9.  An evidence-based medicine audit of the ophthalmic emergency services unit of King Abdulaziz University Hospital (KAUH).

Authors:  Adel Alsuhaibani; Mohammed AlRajeh; Priscilla Gikandi; Ahmed Mousa
Journal:  Int Ophthalmol       Date:  2017-10-10       Impact factor: 2.031

Review 10.  [Seasonal allergic conjunctivitis].

Authors:  K Schröder; D Finis; S Meller; M Wagenmann; G Geerling; U Pleyer
Journal:  Ophthalmologe       Date:  2017-11       Impact factor: 1.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.